Triglyceride synthesis and hepatitis C virus production: Identification of a novel host factor as antiviral target

Hepatology

Volumn 53, Issue 3, 2011, Pages 1046-1048

  Schuster, Catherine ^a,b   Lefèvre, Mathieu ^a,b   Baumert, Thomas F ^a,b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE INHIBITOR; ANTIVIRUS AGENT; DIACYLGLYCEROL ACYLTRANSFERASE 1; DIACYLGLYCEROL ACYLTRANSFERASE 1 INHIBITOR; DIACYLGLYCEROL ACYLTRANSFERASE 2; FAT DROPLET; HOST FACTOR PROTEIN; NUCLEOCAPSID PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADIPOCYTE; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; CELL CULTURE; DISEASE SEVERITY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY LIVER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INSULIN RESISTANCE; INTESTINE CELL; LIFE CYCLE; LIPID METABOLISM; LIPOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; METABOLIC SYNDROME X; NONHUMAN; NOTE; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; TREATMENT RESPONSE; VIRION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS LOAD; VIRUS NUCLEOCAPSID; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 79952220508     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24177     Document Type: Note

References (12)

1. Negro F. Abnormalities of lipid metabolism in hepatitis C virus infection. Gut 2010; 59: 1279-1287.
2. Georgel P, Schuster C, Zeisel MB, Stoll-Keller F, Berg T, Bahram S, et al. Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies. Trends Mol Med 2010; 16: 277-286.
3. Jones DM, McLauchlan J. Hepatitis C virus: assembly and release of virus particles. J Biol Chem 2010; 285: 22733-22739.
4. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 2007; 9: 1089-1097.
5. Martin S, Parton RG. Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol 2006; 7: 373-378.
6. Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, et al. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 2008; 4: e1000035.
7. Tellinghuisen TL, Foss KL, Treadaway J. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog 2008; 4: e1000032.
8. Benga WJ, Krieger SE, Dimitrova M, Zeisel MB, Parnot M, Lupberger J, et al. Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles. HEPATOLOGY 2010; 51: 43-53.
9. Herker E, Harris C, Hernandez C, Carpentier A, Kaehlcke K, Rosenberg AR, et al. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 2010; 16: 1295-1298.
10. Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV Jr. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res 2008; 49: 2283-2301.
11. Birch AM, Buckett LK, Turnbull AV. DGAT1 inhibitors as anti-obesity and anti-diabetic agents. Curr Opin Drug Discov Devel 2010; 13: 489-496.
12. Villanueva CJ, Monetti M, Shih M, Zhou P, Watkins SM, Bhanot S, et al. Specific role for acyl CoA: diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids. HEPATOLOGY 2009; 50: 434-442.